1. Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update
   Faria Sultana et al, 2020, Current Medicinal Chemistry CrossRef
2. Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma
   Oliver J. Pickering et al, 2021, Cancers CrossRef
3. The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance
   Catarina Macedo-Silva et al, 2019, Genes CrossRef
4. Epigenetic modifications in esophageal cancer: An evolving biomarker
   Wen-Jian Liu et al, 2023, Frontiers in Genetics CrossRef
5. Novel milestones for early esophageal carcinoma: From bench to bed
   Ji-Han Qi et al, 2024, World Journal of Gastrointestinal Oncology CrossRef
6. Histone deacetylase inhibitors selectively suppress expression of HDAC7
   Milos Dokmanovic et al, 2007, Molecular Cancer Therapeutics CrossRef
7. ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer
   David Vrana et al, 2018, International Journal of Molecular Sciences CrossRef